ALVAL — Valbiotis SA Income Statement
0.000.00%
Last trade - 00:00- €16.02m
- €3.57m
- €4.73m
Annual income statement for Valbiotis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.091 | 3.09 | 0.298 | 0.785 | 4.73 |
| Cost of Revenue | |||||
| Gross Profit | -0.154 | 2.52 | -0.119 | 0.224 | 2.31 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.25 | 6.5 | 8.77 | 12.8 | 11.9 |
| Operating Profit | -5.16 | -3.41 | -8.47 | -12 | -7.18 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.5 | -3.83 | -8.68 | -12.3 | -7.37 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.5 | -3.83 | -8.68 | -12.3 | -7.37 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.5 | -3.83 | -8.68 | -12.3 | -7.37 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.5 | -3.83 | -8.68 | -12.3 | -7.37 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.17 | -0.514 | -0.948 | -1.22 | -0.591 |
| Dividends per Share |